Surmodics | SRDX - Ebit





Ebit Veränderung Datum
Abbott USD 2.54B 358M 2025-12
Align Technology USD 224.71M 40.06M 2025-12
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
Artivion USD 4.79M 6.85M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
EDAP TMS EUR -4.92M 843K 2025-09
Edwards Lifesciences USD 370.3M 54.8M 2025-12
Haemonetics USD 67.4M 13.71M 2025-12
Heron Therapeutics USD 38K 3.83M 2025-12
J&J USD 5.11B 2.3B 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Mesa Laboratories USD 4.45M 2.5M 2024-09
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Option Care Health USD 91.5M 6.99M 2025-12
Stryker USD 1.97B 609M 2025-12
Surmodics USD 58K 380K 2025-06
Trinity Biotech USD -10.02M 8.31M 2024-12